Xenon Pharmaceuticals (XENE) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.18
-1.06
-0.95
-0.83

Details

Expected EPS
-1.179498
Actual EPS
-1.17
Surprise EPS
0.01
Surprise Percent
+0.81%

Description

⁨Xenon Pharmaceuticals⁩ (⁦XENE⁩) has reported earnings of ⁦-1.17⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts